2m 2m 2m 2m 2m 2m 2m
APREA THERAPEUT (APRE)
NASDAQ
$0.44-$0.002 (-0.36%)
Price as of Nov 11, 2026 7:55 PM EST- $6.3MMarket Cap
- -66.24%1-Year Change
- BiotechnologyIndustry
APREA THERAPEUT (APRE)
$0.44-$0.002 (-0.36%)
APRE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.45 | ||
Change | -$0.06 (-11.06%) | ||
Open | $0.50 | ||
High | $0.51 | ||
Low | $0.44 | ||
Previous Close | $0.50 | ||
Volume | 158,772 | ||
30-Day Average Volume | 149,632 | ||
1-Week Change | -13.48% | ||
1-Month Change | -26.27% | ||
1-Year Change | -66.24% | ||
3-Year Change | -88.40% | ||
5-Year Change | -99.55% | ||
Fundamentals | |||
Shares Outstanding | 14.2M | ||
Total Assets | $38.8M | ||
Market Cap | $6.3M | ||
Enterprise Value | -$31.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$4.8M | ||
Free Cash Flow | -$3.7M | ||
EBIT | -$4.8M | ||
EBITDA | -$4.8M | ||
Net Working Capital | $34.5M | ||
EPS | -$0.09 | ||
Enterprise Value/EBITDA | 7 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 02/13/2023 | ||
Earnings & Revenue